Gene Therapy Helps Patients with Hemophilia
A single dose of an experimental gene therapy boosted production of a missing blood-clotting factor in people with hemophilia, a new study shows. The therapy might give patients a long-term solution for preventing dangerous bleeding episodes. Hemophilia is a rare, inherited disorder in which blood is unable to clot normally. As a result, people with hemophilia tend to bleed more than others
Post a Comment
Post a Comment